| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
EXTENDED REPORT |
1 2nd Medical Department, University Hospital of Schleswig-Holstein, Kiel, Germany
2 Department of Nuclear Medicine, University Hospital of Schleswig-Holstein, Kiel
Correspondence to:
Correspondence to:
Dr Frank Moosig
2nd Medical Department, University Hospital of Schleswig-Holstein, Campus Kiel, Chemnitzstr 33, 24116 Kiel, Germany; fmoosig{at}aol.com
Objective: To quantify 18-fluorodeoxyglucose (FDG) accumulation in large vessels in patients with polymyalgia rheumatica by positron emission tomography (PET), and to compare these data with serological markers of inflammation.
Methods: 13 untreated patients with active polymyalgia rheumatica underwent FDG positron emission tomography; eight were analysed in a second PET when in clinical remission. Six patients with other highly inflammatory conditions served as controls. For quantitative analysis, FDG uptake over nine defined vascular regions, divided by an individual background value, was expressed as a region of interest (ROI) index. These data were compared with the clinical status of the patient and with erythrocyte sedimentation rate (ESR), C reactive protein, haemoglobin, and platelet and leucocyte counts.
Results: By visual evaluation, 12 of the 13 patients showed an increased tracer uptake of the aorta or its major branches. By quantitative analysis, FDG uptake was significantly increased in polymyalgia rheumatica. In patients with active disease, the mean ROI index for all vascular regions exceeded that of controls by 70% (mean (SD): 1.58 (0.37) v 0.93 (0.12); p<0.001). In the eight patients who underwent follow up PET, the index declined substantially. In active polymyalgia rheumatica, FDG uptake was significantly correlated with C reactive protein (r = 0.8), ESR (r = 0.79), and platelet counts (r = 0.68).
Conclusions: The observed FDG accumulation in the aorta and its branches and a strong correlation between tracer uptake and markers of inflammation is suggestive of large vessel arteritis. Quantitative ROI analysis appears to be a sensitive tool for detecting such inflammation.
Keywords: polymyalgia rheumatica; positron emission tomography; serology
This article has been cited by other articles:
|
|
 |
|
  H. Hautzel, O. Sander, A. Heinzel, M. Schneider, and H.-W. Muller Assessment of Large-Vessel Involvement in Giant Cell Arteritis with 18F-FDG PET: Introducing an ROC-Analysis-Based Cutoff Ratio J. Nucl. Med., July 1, 2008; 49(7): 1107 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Both, K Ahmadi-Simab, M Reuter, O Dourvos, E Fritzer, S Ullrich, W L Gross, M Heller, and M Bahre MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis Ann Rheum Dis, July 1, 2008; 67(7): 1030 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Blockmans, L. De Ceuninck, S. Vanderschueren, D. Knockaert, L. Mortelmans, and H. Bobbaers Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients Rheumatology, April 1, 2007; 46(4): 672 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dejaco, C. Duftner, E. Wipfler, and M. Schirmer 18F-Flourodeoxyglucose positron emission tomography in polymyalgia rheumatica: novel insight into complex pathogenesis but questionable use in predicting relapses Rheumatology, April 1, 2007; 46(4): 559 - 560. [Full Text] [PDF]
|
|
|
|
|
|
D Wendling, O Blagosklonov, G Streit, G Lehuede, E Toussirot, and J-C Cardot FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short term evolution during anti-tumour necrosis factor treatment Ann Rheum Dis, November 1, 2005; 64(11): 1663 - 1665. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
